Treatment for in-stent restenosis using drug-eluting balloon: Importance of procedural optimization rather than device itself

Int J Cardiol. 2017 Sep 1:242:5. doi: 10.1016/j.ijcard.2017.02.110.

Authors

Joo Myung Lee¹, Tae-Min Rhee², Jonghanne Park², Hyo-Soo Kim³

Affiliations

¹ Division of Cardiology, Department of Internal Medicine, Heart Vascular Stroke Institute, Samsung Medical Center, Seoul, Republic of Korea.
² Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea.
³ Department of Internal Medicine and Cardiovascular Center, Seoul National University Hospital, Seoul, Republic of Korea. Electronic address: [email protected].

PMID: 28619351
DOI: 10.1016/j.ijcard.2017.02.110

No abstract available

Keywords: Drug-eluting balloon; Drug-eluting stents; In-stent restenosis; Percutaneous coronary intervention.

Publication types

Letter
Comment

MeSH terms

Coronary Angiography
Coronary Restenosis*
Drug-Eluting Stents*
Humans
Paclitaxel
Stents
Treatment Outcome

Substances

Paclitaxel